User blogs

We love how this mindbodygreen.com article describes L-theanine as, “the closest thing we’ve got to meditation in a bottle.” This article also describes several other benefits associated with this amino acid, from boosting attention, mood and sleep quality to boosting creativity.*

Suntheanine is a clinically proven, Non-GMO Project Verified L-theanine supplement. It’s produced via a patented process that results in 100 percent pure L-theanine, ensuring safety, potency, consistency and quality.

Here’s a quick look at what mindbodygreen had to say about L-theanine:

L-theanine promotes a soothing brain wave pattern.*
L-theanine has been clinically shown to increase alpha brain waves. These brain waves promote relaxation without drowsiness.* “Alpha brain-wave production also happens during deep meditation, when sensory inputs are minimized and the mind is generally clear of unwanted thoughts or distractions. Interestingly, stimulating alpha waves has also been shown to boost creativity and alleviate depression.”

Human clinical trials have shown that Suntheanine increases alpha brain waves, as well as decreases beta brain waves. Beta waves promote an excited state.

L-theanine may help support attention and working memory.*
According to the article, green tea consumption – L-theanine is naturally found in green tea – has been shown to enhance performance on tests of working memory by increasing connectivity within the brain during processing. “This is a fascinating discovery because activity in the frontal region of the brain is correlated to executive function, while the parietal region handles sensory input.”

L-theanine may slow or reduce cognitive decline.
The article references a study which showed that elderly individuals who consumed L-theanine-enriched green tea powder had reduced cognitive decline compared with a placebo group.

L-theanine may help improve mood.*
L-theanine helps improve the production of GABA, a relaxing neurotransmitter. “GABA is important for nervous system function; (it’s) often used as a natural supplement to promote sleep, improve mood, and ease anxiety,” the article explains.

L-theanine may improve sleep quality*
L-theanine encourages relaxation which helps calm the mind, making it easier to get longer and more restful sleep. The article also references a clinical study which used Suntheanine. In this study, researchers demonstrated that Suntheanine safely and effectively improved the sleep quality of 8 to 12-year-old boys with ADHD.

Dietary Supplement Nootropics Supplement Powder PRL-8-53 powder
Basic Info.
Name:PRL-8-53
Chemical name:Methyl 3-(2-(benzyl(methyl)amino)ethyl)benzoate
Synonyms:PRL-8053;PRL-8-53;Methyl 3-(2-(benzyl(Methyl)aMino)ethyl)benzoate hydrochloride;3-(2-Benzyl(methyl)aminoethyl)benzoic acid methyl ester hydrochloride;m-[2-(Benzylmethylamino)ethyl]benzoic acid methyl ester hydrochloride;Benzoic acid, 3-(2-(Methyl(phenylMethyl)aMino)ethyl)-, Methyl ester, hydrochloride
CAS 51352-87-5
MF:C18H22ClNO2
MW 319.82578
Shelf life:2 years
Purity:99%
Package:50g/foil bag or as your inquiry
Dosage:
Subjects in human trials have been given up to 100 mg a day and did not appear to develop any negative side effects.
Reference FOB Price:$1/g
MOQ:10g
Specification:ISO9001,USP,BP,GMP
Trade Mark:CQSP
Port:Shenzhen/Shanghai,China
Production Capacity:5000kg/month
Skype/E-mail : summer at chembj.com
Abstract
The effect of 3-(2-benzylmethylaminoethyl) benzoic acid methyl ester hydrochloride (PRL-8-53) on learning and on retention of verbal information in human subjects was investigated. Using the serial anticipation method under double-blind conditions it was found that PRL-8-53 causes slight improvement of acquisition. Retinetion of verbal information was found improved to a statistically significant degree (most P values better than 0.01, some better than 0.001). No significant changes were found for either visual reaction time or motor control after drug when compared with placebo values.
Description
PRL-8-53 (chemical name Methyl 3-(2-(benzyl(methyl)amino)ethyl)benzoate) is a synthetic nootropic compound discovered in 1972 and patented in 1975 by the late Dr. Nikolaus Hansl, a neuropharmacologist at Creighton University in Omaha, Nebraska. Preliminary animal tests indicated that the compound was both safe and significantly nootropic, boosting avoidance learning in rodents with no adverse effects. But the real interest in PRL-8-53 was sparked by a 1978 study on human volunteers, which showed that a single dose of the compound could improve word retention scores by more than 200%.
HOW IT WORKS?
PRL-8-53's exact mechanisms of action are not well understood, but it is generally believed to regulate the brain's production of and response to several crucial neurotransmitters. In his reports on human and animal studies Hansl indicated that PRL-8-53 potentiates dopamine, partially restricts production of serotonin, and enhances the brain's response to acetylcholine.
Though Hansl's research report on the 1978 human study suggests those actions, it does not clearly delineate the mechanism of action.The fact that older subjects saw the most nootropic benefit from taking the drug supports the concept that dopamine modulation plays a major role in PLR-8-53's effects. Up-regulating the normal age-related lessening of dopamine production that is associated with cognitive decline could have a significant positive impact on both learning and memory.
Dosage
The only human study on PRL-8-53 was based on the ingestion of a single 5 mg dose. There is no data on the effectiveness or potential toxicity of any other dosage in humans.
SIDE EFFECTS
No adverse effects from a single 5 mg dose of PRL-8-53 were observed in the human study. Animal studies suggest that the compound has a high therapeutic threshold, but evidence is very limited because no comprehensive toxicity studies have been completed.

Lorcaserin Hydrochloride is an FDA-approved prescription weight-loss medication that, when used with diet and exercise, can help some overweight adults with a weight-related medical problem, or obese adults, lose weight and keep it off.Lorcaserin powder

Lorcaserin HCl is an FDA-approved prescription weight-loss medication that, when used with diet and exercise, can help some overweight adults with a weight-related medical problem, or obese adults, lose weight and keep it off.
Lorcaserin hydrochlorideis a serotonin 2C receptor agonist. It hasbeen shown to decrease food consumption and promote SA tiety by selectivelyactivating serotonin 2C receptors in the brain.

Lorcaserin HCl is specifically indicated as an adjunct to a reduced-calorie diet andincreased physical activity for chronic weight management in clinically obeseadults (BMI of 30 kg/m2 or greater) and overweight adults (BMI of 27 kg/m2 orgreater) with at least one weight-related comorbid condition.

Lorcaserin HCl is supplied as a tablet designed for oral administration. The recommendeddose is one 10mg tablet twice daily. Use of Lorcaserin HCl should be discontinued if 5%weight loss is not achieved by week 12 of treatment.

Sunifiram (DM-235) is a piperazine derived ampakine drug which acts as a positive allosteric modulator of AMPA receptors, and has nootropic effects in animal studies with significantly higher potency than piracetam. A number of related compounds are known, the best known being unifiram (DM-232).Sunifiram powder

application:
Sunifiram is one of the newest nootropics on the market to smart drugs family. It is considered to be in the ampakine family of supplements. It increases one's attention span, decision making, and learning abilities. Although it is believed to work much like Piracetam, it is highly potent in comparison. The structure is similar, but some have reported Sunifiram being 1000 times more potent. In terms of its potency, it's comparable to Noopept.
It is being researched as a memory enhancer, potentially treating Alzheimer's patients. It provides a wide variety of benefits including; increased attention span, improved focus, and increased learning potential. It has become very popular since its release, as the benefits are high and the side-effects are low.

How to Use Sunifiram:
Sunifiram is extremely potent, so small doses should be taken. It has been said that it works best when taken sublingually. This means that users place it under their tongue for administration. This will generally be a little scoop of powder. Some users have experienced a slight tingling, as you would with a breath mint. Ingestion has been reported as easy.
Start with the smallest dose, seeing how you feel. Most users report feeling the effects within an hour of administration. You can always increase your dosage after a week or so. Since dosing is still being studied, do not exceed 10 mg. Use it sparingly or choose to cycle your doses. This means that you will cycle 'on' and 'off.' Spreading out your doses over the course of the week, and then taking a break.
When purchasing online, you may notice that Sunifiram costs slightly more than other nootropics. Keep in mind that the dosage is much smaller than other nootropics. You only need a little to achieve big results. This is due to the potency offered.

Function:
Sunifiram activates AMPA-mediated neurotransmission.
Enhancing LTP in a bell-shaped dose-response relationship.
Sunifiram aids in the release of acetylcholine in the cerebral cortex.
Sunifiram increases energy levels, allowing users to feel more motivated and eliminate
Sunifiram increase Levels of concentration increase, and users feel less distracted by external stimuli.
Sunifiram also enhances long-term potentiation, which is the forming of new connections regarding memory storage.
Sunifiram has some anxiolytic benefits. Feeling more relaxed is beneficial when trying to focus.

The production of melatonin by the pineal gland is activated by darkness and . increased production and release of melatonin, and eventually of pinoline and Deep Breathing Techniques to - Meditation - (Ajna) Chakra. Pinoline is a methoxylated tryptoline (5-methoxytryptoline) long claimed to be produced in the Aluminium toxicity causes an increase in lipid peroxidation, with most damage occurring in the brain. Lipopolysaccharide is produced by Gram-negative bacteria and stimulates the production of free radicals which in turn. Pinoline also resonates with the very pulse of life 8 cycles per second, the pulse the .. and hence there is an increased production of Meltaonin and Pinoline.pinoline powder

Melatonin is then converted in small amounts to pinoline. Production of melatonin is inhibited by light on the retina and then increases in Melatonin also seems to boost the immune system and slow the aging process. hyde (MDA) plus 4-hydroxyalkenals (4-HDA) production as a reflection of lipid peroxidation. Below .. melatonin did not improve the activity of pinoline in. increases in length during the sleep cycle, often . REMS. Pinoline increases brain serotonin levels, production of psychedelic compounds to account.

The pineal gland starts to increase the production of 'pinoline', whereby a greater fluidity of thought and healing of the body starts to occur. (1) Pinoline and melatonin are both structurally related to serotonin .. 5-HT1A and 5-HT2 is known to increase the neurogenesis rate in adult rat brain. The production of H2O2 catalyzed by MAO isoforms was detected using. This "Third Eye,” in the center of the brain, is implicated in the production of endogenous .. DMT with Pinoline increases brain activation, and with its cousin the. SNP increased MDA + 4-HDA and carbonyl contents production in brain homogenates Keywords: Melatonin; Pinoline; Nitric oxide; Lipid peroxidation; Protein. Therefore, increased production of endogenous KYNA might (similar to exogenous antagonist, MK) inhibit NAS biosynthesis and contribute to.

Request PDF on ResearchGate | Antioxidant activity of pinoline analogues in the replacement of this methoxy by an Et side chain increased the antioxidant. Aging is associated with increased production of reactive oxygen species .. Pinoline and N-acetylserotonin reduce glutamate-induced lipid. Pinoline, 6-methoxy-1,2,3,4-tetrahydro-β-carboline, is a serotonin analog have impaired or deficient CYP2D6 activity, they may have increased risk so that the rates of metabolite production were within the linear ranges. question the relevance of the neuroendocrine production of pinoline. . nitrogen in γ-position abolished the binding to 5-HT1AR receptors, but increased the.

Anti-NMDA receptor encephalitis is a severe encephalopathic autoimmune disease, which affects mainly young women with ovarian teratoma, but also women without tumors, men and children. First described in 2007, it is a currently still widely under diagnosed disease entity (J. Dalmau et al., 2008, Lancet Neurol 7(12): 1091-1098).N-Methyl-D-Aspartic Acid

Diagnosis of anti-NMDA receptor encephalitis is based on the detection of highly specific autoantibodies directed against glutamate receptors of type NMDA in serum or cerebrospinal fluid. These autoantibodies are detected with high sensitivity and specificity in indirect immunofluorescence using a human recombinant cell line expressing the major target antigen (receptor subunit NR1). The determination of antibodies against glutamate receptors (type NMDA) is of high significance in patients with encephalitis where no pathogen has been detected, as well as in suspected cases of limbic encephalitis. The new cell substrate can be combined with various tissue substrates that are relevant for differential diagnostics (e.g. hippocampus and cerebellum) as BIOCHIP Mosaics, allowing the detection of further autoantibodies associated with limbic encephalitis (e.g. anti-VGKC antibodies, anti-AMPA receptor antibodies)

The question many of us continually ask, “What might be the next clandestine doping agent in sports?” might have a new answer: noopept. Popular in dietary supplements, noopept could be the next big banned substance in sport after meldonium.Noopept powder
As we watch the 2016 Rio Olympic Games with the Russian doping scandal looming in the rearview mirror the notion that noopept could be the next big banned substance in sport after meldonium is interesting on its own. However, when one considers that both substances appear to be sold as medication in Russia, and that many of the meldonium findings early this year involved Russian athletes, the intrigue gets deeper. Because noopept is prevalent in the supplement marketplace around the world, if it is the next clandestine doping agent the potential issue would expand well beyond Russia.
A comparison between the substance noopept and meldonium supports our theory. Meldonium, which is suggested to improve blood flow, is approved for use as anti-ischemia medication in Eastern Europe and Russia. It is usually used to treat heart disease. Although clearly popular with athletes, based on the hundreds of adverse analytical findings for the drug in early 2016, meldonium is not commonly found as a dietary supplement, at least not yet.
Meanwhile, noopept, is patented by JSC LEKKO Pharmaceuticals, a Russian pharmaceutical company, in both the U.S. and Russia. It is commonly sold as a dietary supplement in the nootropic category around the world, but appears to be sold as a medication in Russia and Eastern Europe. Noopept is being studied for its potential to alleviate Alzheimer’s symptoms and treat other brain disorders. It is not an approved drug in the U.S.
Noopept does not appear to be a controlled substance in the U.S. or other countries, or at least that is what some nootropic sites claim. That does not mean, however, it would be legal to sell as a supplement. It would likely qualify as an unapproved drug according to the U.S. FDA, or other international equivalents. As such, it may be OK to sell for research purposes, but not as a supplement marketed for human consumption. Given that noopept was patented in 1996, was not in the food supply prior to 1994, and is synthetic, it does not appear to qualify as a legal dietary supplement ingredient in the U.S., according to DSHEA (the Dietary Supplement Health and Education Act of 1994).
Despite noopept being a dubious, if not illegal, supplement ingredient, it is commonly found packaged as a supplement and is available online at a wide range of distributors including Amazon.com and Jet.com. Based on its prevalence in dietary supplements and on message boards, it seems it has become quite popular. With discussion on ‘The Worlds Most Trusted Anabolic Website,’ as far back as 2007, it appears folks that track performance-enhancing compounds have known about it for a number of years.
In fact, noopept has become so popular that even Reddit, who thankfully realizes the concern, has a note on noopept in ‘New Rules in Regards to Illegal/Dangerous Compounds.’ The note describes that, “synthetic drugs (not DSHEA compliant) that have too little information on them to assess toxicity (Ex. Noopept or PRL-8-53)…, are in the grey area.”

Mobile phones can become office VoIP phones with the Invoxia 610, a device that Invoxia will be demonstrating at the International CES this week.fixed wireless gsm desk phone

Last year, the French company introduced the AudiOffice, an iPhone docking station with a wired handset and a set of six speakers for high-powered conference calling and music listening. Putting an iPhone in the dock made it into something like a full-size speakerphone, while the handset let consumers use it like a traditional desk phone.

Now Invoxia has combined those capabilities with VoIP in the NVX 610, a version of its desk phone that plugs into an office network via Ethernet. The company showed it off at a CES kickoff event on Sunday. It's due to ship in the first quarter of this year.
With the new system, workers can make and receive VoIP calls on the wired handset in the unit, which has its own keypad and display, or from an Invoxia app on their cell phone via Bluetooth.

It's a sleek, low, white unit that carries a list price of a cool US$599, which is $300 more than the original, non-VoIP Invoxia product. But it lets users tap into the cost savings and features of office VoIP with the phone they're most comfortable using or have with them at the moment. Speakerphone is still an option, too.

Invoxia also plans to expand the device options on its whole line this quarter by including a variety of dock interfaces for the iPhone 5 and for Android phones. An Android app is on the way to work with phones running any version of Android. There's even a special adapter that lets the user mount an iPad on the back of the device and plug it in via a standard iPad mount. Support for Android tablets will come later, said Pascal Dussiau, vice president of sales at Invoxia.

A new report by renowned analysts Mobile Experts says the global Fixed Wireless Access (FWA) equipment market will grow from a value of $3.2 billion last year to more than $6.2 billion by 2024 corresponding to a CAGR of 11% per year. Significant market expansion of 802.11-based systems in the 24-40 GHz and 60 GHz millimetre-wave bands contribute to the growth, Mobile Experts says.cdma fixed wireless terminal

The growth is consequential and sign of good years ahead for vendors working mostly with 802.11-based technology, such as Cambium Networks, Ubiquiti Networks, and others capable of extending products into new spectrum bands. By shipment volume of dedicated base station access points the market share for 802.11-based systems is about 75%, the company says.

Mobile Experts attributes most of the growth in 802.11-based FWA to millimetre-wave systems. “While the overall 802.11-based FWA access point shipment is forecasted to grow modestly at 2% CAGR from 2018 to 2024, those utilising the millimetre wave bands are expected to grow at over 16% CAGR,” says Mobile Experts’ Principal Analyst Kyung Mun.
The report and forecast includes all of 4G, 5G, and 802.11-based technologies. “Because 5G FWA systems are more costly and with numbers primarily driven by CPE sales, 5G represents over half of the market value for FWA although only about 40% of the actual CPE shipment volume in 2024,” says Joe Madden, Founder & President of Mobile Experts.
Kyung Mun says the drivers are well known. “Fundamentally, people in both urban and rural areas want faster Internet connectivity and an increasing number of streaming options is aiding in this trend. The pent-up demand is hard to ignore,” he says.

Mobile Experts is careful to point out that the report includes only ‘dedicated FWA networks’ and not FWA-type applications running on infrastructure shared with 4G or 5G. Shipment numbers include both radios and CPEs but excludes wireless backhaul, which are common in remote deployments, Mobile Experts says.

The global fixed wireless broadband market will grow 30% in 2018 and generate $18 billion in service revenue, forecasts market analysis firm ABI Research. By 2022, worldwide fixed wireless broadband market are expected to generate $45.2 billion, thanks to an estimated compound annual growth rate of 26%.cdma fixed wireless phone

Fixed wireless broadband delivers broadband via radio signals rather than cables to deliver broadband internet to customers, who have an outdoor antenna receiver mounted to the building and a Wi-Fi gateway inside. The connection is line-of-sight between the customer premises and a ground station.

Often fixed broadband options — DSL, cable or fiber alternatives — are limited in rural areas, explains network infrastructure company Ericsson in a blog. “Fixed wireless access (FWA) provides a bridge to those potential customers,” Ericsson said.

As RCR Wireless News reported in March, lots of small, rural carriers are working to extend reliable broadband in challenging economic and geographical settings.

For now, LTE is the most widely used technology to provide fixed wireless broadband service across the world, reports ABI Research. Verizon will launch its 5G fixed wireless in California this year and expects 30 million customers to be reached by that first deployment. AT&T and Charter are carrying out 5G fixed wireless broadband tests in select U.S. markets. Orange, Elisa, and telecom infrastructure company Arqiva are performing 5G fixed wireless trials in Europe. In APAC, Australia’s Optus is planning for 5G fixed wireless service launch in 2019, , according to ABI Research.

“5G fixed broadband access is expected to enable robust services with a reliable capacity to meet the need of residential broadband users,” said ABI Research Industry Analyst Khin Sandi Lynn in a statement. “5G technology can support a theoretical speed up to 20 Gbps with latency [of]1 ms, enabling operators to provide superior broadband access without installing fiber-optic cables to every single household,”

These findings are from ABI Research’s LTE and 5G Fixed Broadband Markets report, which lists 43 operators providing fixed wireless broadband access including AT&T, Bell, Orange, Telefonica, Verizon, etc. and customer premises equipment vendors including Arris, Huawei, Netgear, Sagemcom, Technicolor, ZyXel, ZTE, among others.